Need help finding what you are looking for?
Contact Us
PUBLISHER: TechNavio | PRODUCT CODE: 1398153
PUBLISHER: TechNavio | PRODUCT CODE: 1398153
Global Behcet's Disease Therapeutics Market 2024-2028
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Abstract
The behcet's disease therapeutics market is forecasted to grow by USD 437.57 mn during 2023-2028, accelerating at a CAGR of 6.82% during the forecast period. The report on the behcet's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases.
| Market Scope | |
|---|---|
| Base Year | 2023 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 5.7% |
| CAGR | 6.82% |
| Incremental Value | $437.57mn |
Technavio's behcet's disease therapeutics market is segmented as below:
By Route Of Administration
- Oral
- Injectable
By Product
- Small molecules
- Biologics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing awareness about rare diseases as one of the prime reasons driving the behcet's disease therapeutics market growth during the next few years. Also, strategic alliances among vendors and the advent of novel therapeutics will lead to sizable demand in the market.
The report on the behcet's disease therapeutics market covers the following areas:
- Behcet's disease therapeutics market sizing
- Behcet's disease therapeutics market forecast
- Behcet's disease therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading behcet's disease therapeutics market vendors that include AbbVie Inc., Amgen Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson, Mitsubishi Chemical Group Corp., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Viatris Inc., and Xoma Corp.. Also, the behcet's disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Product Code: IRTNTR73638
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Behcets disease therapeutics market 2018 - 2022
- Exhibit 18: Historic Market Size - Data Table on global behcets disease therapeutics market 2018 - 2022 ($ million)
- 4.2 Route of Administration Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
- 4.3 Product Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration
- 6.1 Market segments
- Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
- 6.2 Comparison by Route of Administration
- Exhibit 32: Chart on Comparison by Route of Administration
- Exhibit 33: Data Table on Comparison by Route of Administration
- 6.3 Oral - Market size and forecast 2023-2028
- Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
- 6.4 Injectable - Market size and forecast 2023-2028
- Exhibit 38: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Injectable - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Route of Administration
- Exhibit 42: Market opportunity by Route of Administration ($ million)
- Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
7 Market Segmentation by Product
- 7.1 Market segments
- Exhibit 44: Chart on Product - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
- 7.2 Comparison by Product
- Exhibit 46: Chart on Comparison by Product
- Exhibit 47: Data Table on Comparison by Product
- 7.3 Small molecules - Market size and forecast 2023-2028
- Exhibit 48: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
- 7.4 Biologics - Market size and forecast 2023-2028
- Exhibit 52: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Biologics - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Product
- Exhibit 56: Market opportunity by Product ($ million)
- Exhibit 57: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Japan - Market size and forecast 2023-2028
- Exhibit 83: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 Canada - Market size and forecast 2023-2028
- Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.11 Germany - Market size and forecast 2023-2028
- Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Exhibit 99: Market opportunity By Geographical Landscape ($ million)
- Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 104: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 105: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification
- 12.3 AbbVie Inc.
- Exhibit 107: AbbVie Inc. - Overview
- Exhibit 108: AbbVie Inc. - Product / Service
- Exhibit 109: AbbVie Inc. - Key news
- Exhibit 110: AbbVie Inc. - Key offerings
- 12.4 Amgen Inc.
- Exhibit 111: Amgen Inc. - Overview
- Exhibit 112: Amgen Inc. - Product / Service
- Exhibit 113: Amgen Inc. - Key offerings
- 12.5 F. Hoffmann La Roche Ltd.
- Exhibit 114: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 115: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 116: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 117: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 118: F. Hoffmann La Roche Ltd. - Segment focus
- 12.6 Johnson and Johnson
- Exhibit 119: Johnson and Johnson - Overview
- Exhibit 120: Johnson and Johnson - Business segments
- Exhibit 121: Johnson and Johnson - Key news
- Exhibit 122: Johnson and Johnson - Key offerings
- Exhibit 123: Johnson and Johnson - Segment focus
- 12.7 Mitsubishi Chemical Group Corp.
- Exhibit 124: Mitsubishi Chemical Group Corp. - Overview
- Exhibit 125: Mitsubishi Chemical Group Corp. - Business segments
- Exhibit 126: Mitsubishi Chemical Group Corp. - Key offerings
- Exhibit 127: Mitsubishi Chemical Group Corp. - Segment focus
- 12.8 Novartis AG
- Exhibit 128: Novartis AG - Overview
- Exhibit 129: Novartis AG - Business segments
- Exhibit 130: Novartis AG - Key offerings
- Exhibit 131: Novartis AG - Segment focus
- 12.9 Pfizer Inc.
- Exhibit 132: Pfizer Inc. - Overview
- Exhibit 133: Pfizer Inc. - Product / Service
- Exhibit 134: Pfizer Inc. - Key news
- Exhibit 135: Pfizer Inc. - Key offerings
- 12.10 Takeda Pharmaceutical Co. Ltd.
- Exhibit 136: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 137: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 138: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 139: Takeda Pharmaceutical Co. Ltd. - Key offerings
- 12.11 Viatris Inc.
- Exhibit 140: Viatris Inc. - Overview
- Exhibit 141: Viatris Inc. - Business segments
- Exhibit 142: Viatris Inc. - Key news
- Exhibit 143: Viatris Inc. - Key offerings
- Exhibit 144: Viatris Inc. - Segment focus
- 12.12 Xoma Corp.
- Exhibit 145: Xoma Corp. - Overview
- Exhibit 146: Xoma Corp. - Product / Service
- Exhibit 147: Xoma Corp. - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 148: Inclusions checklist
- Exhibit 149: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 150: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 151: Research methodology
- Exhibit 152: Validation techniques employed for market sizing
- Exhibit 153: Information sources
- 13.5 List of abbreviations
- Exhibit 154: List of abbreviations
Product Code: IRTNTR73638
Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
- Exhibits6: Executive Summary - Chart on Market Segmentation by Product
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Vendor Market Positioning
- Exhibits10: Parent market
- Exhibits11: Market Characteristics
- Exhibits12: Offerings of vendors included in the market definition
- Exhibits13: Market segments
- Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits18: Historic Market Size - Data Table on global behcets disease therapeutics market 2018 - 2022 ($ million)
- Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
- Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
- Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- Exhibits23: Five forces analysis - Comparison between 2023 and 2028
- Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits29: Chart on Market condition - Five forces 2023 and 2028
- Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
- Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
- Exhibits32: Chart on Comparison by Route of Administration
- Exhibits33: Data Table on Comparison by Route of Administration
- Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
- Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
- Exhibits38: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
- Exhibits39: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
- Exhibits40: Chart on Injectable - Year-over-year growth 2023-2028 (%)
- Exhibits41: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
- Exhibits42: Market opportunity by Route of Administration ($ million)
- Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
- Exhibits44: Chart on Product - Market share 2023-2028 (%)
- Exhibits45: Data Table on Product - Market share 2023-2028 (%)
- Exhibits46: Chart on Comparison by Product
- Exhibits47: Data Table on Comparison by Product
- Exhibits48: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
- Exhibits49: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
- Exhibits50: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
- Exhibits51: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
- Exhibits52: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
- Exhibits53: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
- Exhibits54: Chart on Biologics - Year-over-year growth 2023-2028 (%)
- Exhibits55: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
- Exhibits56: Market opportunity by Product ($ million)
- Exhibits57: Data Table on Market opportunity by Product ($ million)
- Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits61: Chart on Geographic comparison
- Exhibits62: Data Table on Geographic comparison
- Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits83: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibits84: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibits85: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibits86: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits99: Market opportunity By Geographical Landscape ($ million)
- Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
- Exhibits101: Impact of drivers and challenges in 2023 and 2028
- Exhibits102: Overview on Criticality of inputs and Factors of differentiation
- Exhibits103: Overview on factors of disruption
- Exhibits104: Impact of key risks on business
- Exhibits105: Vendors covered
- Exhibits106: Matrix on vendor position and classification
- Exhibits107: AbbVie Inc. - Overview
- Exhibits108: AbbVie Inc. - Product / Service
- Exhibits109: AbbVie Inc. - Key news
- Exhibits110: AbbVie Inc. - Key offerings
- Exhibits111: Amgen Inc. - Overview
- Exhibits112: Amgen Inc. - Product / Service
- Exhibits113: Amgen Inc. - Key offerings
- Exhibits114: F. Hoffmann La Roche Ltd. - Overview
- Exhibits115: F. Hoffmann La Roche Ltd. - Business segments
- Exhibits116: F. Hoffmann La Roche Ltd. - Key news
- Exhibits117: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibits118: F. Hoffmann La Roche Ltd. - Segment focus
- Exhibits119: Johnson and Johnson - Overview
- Exhibits120: Johnson and Johnson - Business segments
- Exhibits121: Johnson and Johnson - Key news
- Exhibits122: Johnson and Johnson - Key offerings
- Exhibits123: Johnson and Johnson - Segment focus
- Exhibits124: Mitsubishi Chemical Group Corp. - Overview
- Exhibits125: Mitsubishi Chemical Group Corp. - Business segments
- Exhibits126: Mitsubishi Chemical Group Corp. - Key offerings
- Exhibits127: Mitsubishi Chemical Group Corp. - Segment focus
- Exhibits128: Novartis AG - Overview
- Exhibits129: Novartis AG - Business segments
- Exhibits130: Novartis AG - Key offerings
- Exhibits131: Novartis AG - Segment focus
- Exhibits132: Pfizer Inc. - Overview
- Exhibits133: Pfizer Inc. - Product / Service
- Exhibits134: Pfizer Inc. - Key news
- Exhibits135: Pfizer Inc. - Key offerings
- Exhibits136: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibits137: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibits138: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibits139: Takeda Pharmaceutical Co. Ltd. - Key offerings
- Exhibits140: Viatris Inc. - Overview
- Exhibits141: Viatris Inc. - Business segments
- Exhibits142: Viatris Inc. - Key news
- Exhibits143: Viatris Inc. - Key offerings
- Exhibits144: Viatris Inc. - Segment focus
- Exhibits145: Xoma Corp. - Overview
- Exhibits146: Xoma Corp. - Product / Service
- Exhibits147: Xoma Corp. - Key offerings
- Exhibits148: Inclusions checklist
- Exhibits149: Exclusions checklist
- Exhibits150: Currency conversion rates for US$
- Exhibits151: Research methodology
- Exhibits152: Validation techniques employed for market sizing
- Exhibits153: Information sources
- Exhibits154: List of abbreviations
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.